ArticleOncotarget2016

Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.

Mary M Heckler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.